$57 Million

Kezar Life Sciences

Follow-on Offering

Lead Left Bookrunner, January 2020

Kezar Life Sciences
Kezar Life Sciences is a clinical-stage biotechnology company developing first-in-class small molecule therapeutics to treat unmet needs in autoimmunity and cancer.